UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

 

 

 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended JulyOctober 31, 2008 or

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            to            

Commission file number 0-5286

 

 

KEWAUNEE SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware 38-0715562

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

2700 West Front Street

Statesville, North Carolina

 28677-2927
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (704) 873-7202

 

 

Indicate by check mark whether the registrantregistrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ¨    Accelerated filer  ¨    Non-accelerated filer  x    Smaller reporting company  ¨

Large accelerated filer¨Accelerated filer¨Non-accelerated filerxSmaller reporting company¨

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

As of SeptemberDecember 5, 2008, the registrant had outstanding 2,556,202 shares of Common Stock.

 

 

 


KEWAUNEE SCIENTIFIC CORPORATION

INDEX TO FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED JULYOCTOBER 31, 2008

 

     Page Number
PART I.FINANCIAL INFORMATION  1
Item 1. Financial Statements  1

Consolidated Statements of Operations - Three and Six months ended JulyOctober 31, 2008 and 2007

1
Consolidated Balance Sheets October 31, 2008 and April 30, 20082
Consolidated Statements of Cash Flows – Six months ended October 31, 2008 and 2007  3

Consolidated Balance Sheets July 31, 2008 and April 30, 2008

4

Consolidated Statements of Cash Flows - Three months ended July 31, 2008 and 2007

5

Notes to Consolidated Financial Statements

  64
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations  97
 Review by Independent Registered Public Accounting Firm  1311
 Report of Independent Registered Public Accounting Firm  1412
Item 3. Quantitative and Qualitative Disclosures About Market Risk  1513
Item 4. Controls and Procedures  1513
PART II.OTHER INFORMATION  14
Item 4. Submission of Matters to a Vote of Security Holders  1614
Item 5.Other Information14
Item 6. Exhibits and Reports on Form 8-K  1614
SIGNATURE  1715

i


Part 1. Financial Information

 

Item 1.Financial Statements

Kewaunee Scientific Corporation

Consolidated Statements of Operations

(Unaudited)

(in thousands, except per share data)

 

  Three months ended
July 31
   Three months ended
October 31
 Six months ended
October 31
 
  2008 2007   2008 2007 2008 2007 

Net sales

  $25,395  $20,784 

Net Sales

  $27,732  $24,727  $53,127  $45,511 

Costs of products sold

   20,044   16,521    21,713   19,174   41,757   35,695 
                    

Gross profit

   5,351   4,263    6,019   5,553   11,370   9,816 

Operating expenses

   3,586   3,148    3,858   3,370   7,444   6,518 
                    

Operating earnings

   1,765   1,115    2,161   2,183   3,926   3,298 

Other income (expense)

   (38)  3    (1)  1   (39)  4 

Interest expense

   (89)  (110)   (93)  (106)  (182)  (216)
                    

Earnings before income taxes

   1,638   1,008    2,067   2,078   3,705   3,086 

Income tax expense

   541   312 

Income Tax expense

   566   658   1,107   970 
                    

Earnings before minority interests

   1,097   696    1,501   1,420   2,598   2,116 

Minority interests in subsidiaries

   116   22    37   208   153   230 
                    

Net earnings

  $981  $674   $1,464  $1,212  $2,445  $1,886 
                    

Net earnings per share

        

Basic

  $0.38  $0.27   $0.57  $0.48  $0.96  $0.75 

Diluted

  $0.38  $0.27   $0.57  $0.47  $0.95  $0.74 

Weighted average number of common shares outstanding (in thousands)

        

Basic

   2,551   2,502    2,555   2,522   2,553   2,512 

Diluted

   2,570   2,521    2,562   2,554   2,566   2,538 

See accompanying notes to consolidated financial statements.

Kewaunee Scientific Corporation

Consolidated Balance Sheets

(in thousands)

 

  July 31,
2008
 April 30,
2008
   October 31,
2008
 April 30,
2008
 
  (Unaudited)     (Unaudited)   

Assets

      

Current assets:

      

Cash and cash equivalents

  $3,131  $3,784   $2,282  $3,784 

Restricted cash

   439   480    408   480 

Receivables, less allowance

   22,969   20,087    25,508   20,087 

Inventories

   7,310   6,984    6,866   6,984 

Deferred income taxes

   405   407    400   407 

Prepaid expenses and other current assets

   841   1,440    1,019   1,440 
              

Total current assets

   35,095   33,182    36,483   33,182 

Property, plant and equipment, at cost

   39,957   39,186    39,983   39,186 

Accumulated depreciation

   (27,915)  (27,361)   (28,307)  (27,361)
              

Net property, plant and equipment

   12,042   11,825    11,676   11,825 

Prepaid pension cost

   1,996   1,936    2,084   1,936 

Other

   3,577   3,663    3,025   3,663 
              

Total other assets

   5,573   5,599    5,109   5,599 
       

Total Assets

  $52,710  $50,606   $53,268  $50,606 
              

Liabilities and Stockholders’ Equity

      

Current liabilities:

      

Short-term borrowings

  $5,707  $4,551   $4,966  $4,551 

Current obligations under capital leases

   291   323    314   323 

Accounts payable

   8,928   8,929    8,687   8,929 

Employee compensation and amounts withheld

   1,444   2,026    1,751   2,026 

Deferred revenue

   695   667    1,374   667 

Other accrued expenses

   1,706   766    1,981   766 
              

Total current liabilities

   18,771   17,262    19,073   17,262 

Obligations under capital leases

   90   153    277   153 

Deferred income tax

   921   921    912   921 

Accrued employee benefit plan costs

   3,488   3,555    2,960   3,555 

Minority interests in subsidiaries

   1,847   1,768    1,708   1,768 
              

Total Liabilities

   25,117   23,659    24,930   23,659 

Stockholders’ equity:

      

Common stock

   6,550   6,550 

Common Stock

   6,550   6,550 

Additional paid-in-capital

   492   489    635   489 

Retained earnings

   23,149   22,373    24,410   22,373 

Accumulated other comprehensive loss

   (2,177)  (2,041)   (2,765)  (2,041)

Common stock in treasury, at cost

   (421)  (424)   (492)  (424)
              

Total stockholders’ equity

   27,593   26,947    28,338   26,947 
              

Total Liabilities and Stockholders’ Equity

  $52,710  $50,606   $53,268  $50,606 
              

See accompanying notes to consolidated financial statements.

Kewaunee Scientific Corporation

Consolidated Statements of Cash Flows

(Unaudited)

(in thousands )thousands)

 

  Three months ended
July 31
   Six months ended
October 31
 
  2008 2007   2008 2007 

Cash flows from operating activities:

      

Net earnings

  $981  $674   $2,445  $1,886 

Adjustments to reconcile net earnings to net cash used in operating activities:

   

Adjustments to reconcile net earnings to net cash (used) by operating activities:

   

Depreciation

   568   494    1,135   974 

Bad debt provision

   33   88 

Provision for deferred income tax expense

   2   —   

Provision for bad debts

   116   147 

Provision for deferred income tax (benefit) expense

   (2)  1 

Decrease in prepaid income taxes

   812   —      812   —   

(Increase) decrease in receivables

   (2,915)  105 

(Increase) decrease in inventories

   (326)  175 

Increase in receivables

   (5,537)  (1,255)

Decrease (increase) in inventories

   118   (552)

Increase in prepaid pension cost

   (60)  (114)   (148)  (229)

Increase (decrease) in accounts payable and other accrued expenses

   357   (1,133)

Increase in accounts payable and other accrued expenses

   698   1,351 

Increase (decrease) in deferred revenue

   28   (960)   707   (793)

Other, net

   (206)  (342)   (847)  107 
              

Net cash used in operating activities

   (726)  (1,013)

Net cash (used) provided by operating activities

   (503)  1,637 

Cash flows from investing activities:

      

Capital expenditures

   (785)  (435)   (679)  (1,135)

Decrease (increase) in restricted cash

   41   (24)   72   (73)
              

Net cash used in investing activities

   (744)  (459)   (607)  (1,208)

Cash flows from financing activities:

      

Dividends paid

   (205)  (175)   (408)  (351)

Increase in short-term borrowings

   1,156   1,067 

Increase (decrease) in short-term borrowings

   415   (1,153)

Payments on capital leases

   (95)  (86)   (192)  (175)

Proceeds from exercise of stock options (including tax benefit)

   6   190 

Purchase of treasury stock

   (198)  —   

Proceeds from exercise of stock options

   276   307 
              

Net cash provided by financing activities

   862   996 

Net cash used in financing activities

   (107)  (1,372)

Effect of exchange rate changes on cash

   (45)  36    (285)  63 
              

Decrease in cash and cash equivalents

   (653)  (440)   (1,502)  (880)

Cash and cash equivalents, beginning of period

   3,784   2,231    3,784   2,231 
              

Cash and cash equivalents, end of period

  $3,131  $1,791   $2,282  $1,351 
              

See accompanying notes to consolidated financial statements.statements

Kewaunee Scientific Corporation

Notes to Consolidated Financial Statements

(unaudited)

 

A.Financial Information

The unaudited interim consolidated financial statements of Kewaunee Scientific Corporation (the “Company” or “Kewaunee”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, although the Company believes that the disclosures are adequate to make the information presented not misleading.

These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s 2008 Annual Report to Stockholders. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.

The preparation of the consolidated financial statements requires management to make certain estimates and assumptions that affect reported amounts and disclosures. Actual results could differ from those estimates.

 

B.Inventories

Inventories consisted of the following (in thousands):

 

  July 31, 2008  April 30, 2008  October 31, 2008  April 30, 2008

Finished products

  $2,410  $1,920  $2,213  $1,920

Work in process

   1,261   1,099   1,503   1,099

Raw materials

   3,639   3,965   3,150   3,965
            
  $7,310  $6,984  $6,866  $6,984
            

For interim reporting, LIFO inventories are computed based on year-to-date quantities and interim changes in price levels. Changes in quantities and price levels are reflected in the interim consolidated financial statements in the period in which they occur.

C.Comprehensive Income

A reconciliation of net earnings and total comprehensive income for the three and six months ended JulyOctober 31, 2008 and 2007 is as follows (in thousands):

 

  Three months ended
July 31, 2008
 Three months ended
July 31, 2007
  Three months ended
October 31, 2008
 Three months ended
October 31, 2007

Net earnings

  $981  $674  $1,464  $1,212

Change in cumulative foreign currency translation adjustments

   (136)  53   (588)  117
            

Total comprehensive income

  $845  $727  $876  $1,329
      
  Six months ended
October 31, 2008
 Six months ended
October 31, 2007

Net earnings

  $2,445  $1,886

Change in cumulative foreign currency translation adjustments

   (724)  170
      

Total comprehensive income

  $1,721  $2,056
      

Assets and liabilities for the Company’s foreign subsidiaries are translated at exchange rates prevailing on the balance sheet date. Revenues and expenses are translated at weighted average exchange rates prevailing during the period and any resulting translation adjustments are reported separately in shareholders’stockholders’ equity.

 

D.Segment Information

The following table provides financial information by business segments for the three and six months ended JulyOctober 31, 2008 and 2007 (in thousands):

 

  Domestic
Operations
  International
Operations
 Corporate Total  Domestic
Operations
  International
Operations
  Corporate Total

Three months ended July 31, 2008

      

Three months ended October 31, 2008

       

Revenues from external customers

  $21,013  $4,382  $—    $25,395  $23,785  $3,947  $—    $27,732

Intersegment revenues

   786   4   (790)  —     851   21   (872)  —  

Operating earnings (loss) before income taxes

   2,040   414   (816)  1,638   2,693   309   (935)  2,067

Three months ended July 31, 2007

      

Three months ended October 31, 2007

       

Revenues from external customers

  $18,014  $2,770  $—    $20,784  $20,080  $4,647   —    $24,727

Intersegment revenues

   776   89   (865)  —     488   221   (709)  —  

Operating earnings (loss) before income taxes

   1,672   (2)  (662)  1,008

Operating earnings (loss) before incomes taxes

   2,268   636   (826)  2,078

Six months ended October 31, 2008

       

Revenues from external customers

  $44,798  $8,329  $—    $53,127

Intersegment revenues

   1,637   25   (1,662)  —  

Operating earnings (loss) before incomes taxes

   4,732   723   (1,750)  3,705

Six months ended October 31, 2007

       

Revenues from external customers

  $38,094   7,417  $—    $45,511

Intersegment revenues

   1,264   310   (1,574)  —  

Operating earnings (loss) before incomes taxes

   3,940   634   (1,488)  3,086

 

E.Defined Pension Plans

The Company has non-contributory defined benefit pension plans covering substantially all salaried and hourly employees. These plans were amended as of April 30, 2005, no further benefits have been, or will be, earned under the plans, subsequent to the amendment date, and no additional participants will be added to the plans. No contributions were paid to the plans during the threesix months ended JulyOctober 31, 2008, and the Company does not expect any contributions to be paid to the plans during the remainder of the current fiscal year.

Pension expense (income) consisted of the following (in thousands):

 

  Three months ended
July 31, 2008
 Three months ended
July 31, 2007
   Three months ended
October 31, 2008
 Three months ended
October 31, 2007
 

Service Cost

  $-0-  $-0-   $-0-  $-0- 

Interest Cost

   228   215    220   215 

Expected return on plan assets

   (337)  (365)   (339)  (365)

Recognition of net loss

   49   35    31   35 
              

Net periodic pension cost (income)

  $(60) $(115)

Net periodic pension income

  $(88) $(115)
       
  Six months ended
October 31, 2008
 Six months ended
October 31, 2007
 

Service Cost

  $-0-  $-0- 

Interest Cost

   448   430 

Expected return on plan assets

   (676)  (730)

Recognition of net loss

   80   70 
       

Net periodic pension income

  $(148) $(230)
       

Recent market conditions have resulted in an unusually high degree of volatility and increased the risks associated with certain investments held by the Company’s pension plans, which has impacted the value of those investments. There has been a negative return on plan assets through October 31, 2008 which could potentially impact the funded status of the plans and the amount of required contributions in future years. The ultimate impact on the funded status will be determined when the annual valuation for the plan year ended April 30, 2009 is performed, based upon the total return of the plan assets for the full year, and will be reflected in the Company’s retirement and benefit plan disclosures at year-end.

F.Credit Arrangement

Item 2. Management’s DiscussionIn October 2008, the Company increased its bank revolving credit facility from $12 million to $14 million under the same terms and Analysisconditions as the original $12 million arrangement.

of Financial Condition and Results of Operations

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

The Company’s 2008 Annual Report to Stockholders contains management’s discussion and analysis of financial condition and results of operations at and for the year ended April 30, 2008. The following discussion and analysis describes material changes in the Company’s financial condition since April 30, 2008. The analysis of results of operations compares the three and six months ended JulyOctober 31, 2008 with the comparable periodperiods of the prior fiscal year.

Results of Operations

Sales for the three months ended JulyOctober 31, 2008 were $25,395,000,$27,732,000, an increase of 22%12% from sales of $20,784,000$24,727,000 in the same period last year. Sales from Domestic Operations were $21,013,000,$23,785,000, an increase of 17%18% from the prior year period. Sales from International Operations were $4,382,000,$3,947,000, a decrease of 15% from the prior year period. The decline in international operations sales resulted from customer changes in their product delivery dates.

Sales for the six months ended October 31, 2008 were $53,127,000, an increase of 58%17% from sales of $45,511,000 in the same period last year. Sales from Domestic Operations were $44,798,000, an increase of 18% from the prior year period. Sales from International Operations were $8,329,000, an increase of 12% from the prior year period. The order backlog at JulyOctober 31, 2008 was $60.4$61.6 million, as compared to a backlog of $58.7 million at April 30, 2008 and $54.7$54.9 million at JulyOctober 31, 2007.

The gross profit margin for the three months ended JulyOctober 31, 2008 was 21.1%21.7% of sales, as compared to 20.5%22.5% of sales in the comparable quarter of the prior year. The increasegross profit margin for the six months ended October 31, 2008 was 21.4% of sales, as compared to 21.6% of sales in the comparable quarter of the prior year. The decreases in gross profit margin wasmargins for the current year period were primarily due to increased manufacturing efficiencies, savings from alternative sources ofhigher raw materials and components, and other cost improvement initiatives, which more than offset higher prices paid during the quarter for certain raw materials,material costs, particularly steel and resin, and for energy and transportation.steel.

Operating expenses for the three months ended JulyOctober 31, 2008 were $3.6 million,$3,858,000, or 14.1%13.9% of sales, as compared to $3.1 million,$3,370,000, or 15.1%13.6% of sales, in the comparable period of the prior year. Operating expenses for the six months ended October 31, 2008 were $7,444,000, or 14.0% of sales, as compared to $6,518,000, or 14.3% of sales, in the comparable period of the prior year. The decreaseincrease in operating expenses as a percentage of salesfor the current quarter was primarily due to most operating expenses staying relatively constant whilean increase of $126,000 in administrative salaries and an increase of $85,000 in sales increased.and marketing expenses. The increase in operating expenses in dollarsfor the current year six-month period, was primarily due to increased expense recordedan increase of $215,000 in administrative salaries, an increase of $190,000 for costs associated with the performance incentive plans, and an increase of $182,000, increased administrative salaries expense of $90,000, and increased$161,000 in sales and marketing expenses of $76,000, partially offset by a decrease of $59,000 in consulting expenses.

Operating earnings were $1,765,000$2,161,000 and $3,926,000 for the three and six months ended JulyOctober 31, 2008. This compares to operating earnings of $1,115,000$2,183,000 and $3,298,000 for the comparable periodperiods of the prior year.

Interest expense was $89,000$93,000 and $182,000 for the three and six months ended JulyOctober 31, 2008, respectively, as compared to $110,000$106,000 and $216,000 for the same periodcomparable periods of the prior year. The decrease in interest expense for the current year periodperiods resulted from lower interest rates paid, partially offset by higher levels of borrowings, as compared to the prior year period.borrowings.

The net of other income and other expense was an expense of $38,000$1,000 and $39,000 in the three and six months ended JulyOctober 31, 2008, respectively, as compared to income of $3,000$1,000 and $4,000 for the comparable periodperiods of the prior year.

Income tax expense of $541,000$566,000 and $1,107,000 was recorded for the three and six months ended JulyOctober 31, 2008, respectively, as compared to income tax expense of $312,000$658,000 and $970,000 recorded for the comparable periodperiods of the prior year. The effective tax rate was 33.0%rates were 27.4% and 29.9% for the three and six months ended JulyOctober 31, 2008, respectively, and was 31.0%were 31.7% and 31.4% for the three and six months ended JulyOctober 31, 2007. The effective tax raterates for each of the three months ended July 31, 2008 differs fromcurrent year and prior year periods were below the statutory rate primarilytax rates due to the impactcombination of varying incomelower tax rates on income earned byin geographic locations of the Company’s foreign subsidiaries. In addition to this factor,subsidiaries and the effective tax rate in the prior year period was favorably impacted by earnedimpact of state and federal income tax credits. The increase incredits on calculated domestic income tax expense. Additionally, income tax expense for the effectivecurrent quarter was reduced by approximately $94,000 for a one-time adjustment for tax ratecredits earned from prior fiscal year capital expenditures resulting from the reinstatement in the current year period as compared to the prior year period resulted primarily from the absencequarter of tax credits no longer available because of the expiration of tax credits allowable to corporations under the United States Federal Research and Environmental Tax Credit Law.Law that had previously expired on December 31, 2007.

Minority interests relate to minority shareholders’ interest in the Company’s two subsidiaries that are not 100% owned by the Company. Minority interests reduced net earnings by $116,000$37,000 and $153,000 for the three and six months ended JulyOctober 31, 2008, as compared to a reduction of $22,000$208,000 and $230,000 for the comparable periodperiods of the prior year. The increasedecrease in minority interests in the current period was directly related to increasedlower earnings of the Company’s two subsidiaries.

Net earnings were $981,000,$1,464,000, or $0.38$0.57 per diluted share, and $2,445,000, or $0.95 per diluted share, for the three and six months ended JulyOctober 31, 2008. This compares toAs stated in the discussion of income tax expense above, net earnings for the quarter ended October 31, 2008 benefited from a one-time adjustment for federal tax credits of $674,000,approximately $94,000, or $0.27$0.04 per diluted share. Net earnings were $1,212,000, or $0.47 per diluted share, and $1,886,000, or $0.74 per diluted share, for the comparable period of the prior year.three and six-months ended October 31, 2007.

Liquidity and Capital Resources

Historically, the Company’s principal sources of liquidity have been funds generated from operations, supplemented as needed by short-term borrowings under the Company’s revolving credit facility. Additionally, certain machinery and equipment are financed by non-cancelablenon-cancellable operating leases or capital leases. The Company believes that these sources will be sufficient to support ongoing business requirements, including capital expenditures through the current fiscal year.

The Company had working capital of $16.3$17.4 million at JulyOctober 31, 2008, compared to $15.9 million at April 30, 2008. The ratio of current assets to current liabilities was 1.9-to-1 at JulyOctober 31, 2008, unchanged from April 30, 2008. At JulyOctober 31, 2008, advances of $5,707,000$4,966,000 were outstanding under the unsecuredCompany’s bank revolving credit facility, as compared to advances of $4,551,000 outstanding as of April 30, 2008. In October 2008, the Company increased the bank credit facility from $12 million to $14 million under the same terms and conditions as the $12 million arrangement.

The Company’s operations used cash of $726,000$503,000 during the threesix months ended JulyOctober 31, 2008. Cash was primarily used to fund an increase of $2,915,000$5,537,000 in accounts receivable, which was partially offset by cash provided from operating earnings.

The Company’s operations usedprovided cash of $1,013,000$1,637,000 during the threesix months ended JulyOctober 31, 2007. Cash was provided primarily used to fund a decreasefrom operations and an increase in accounts payable and other accrued expenses as well aswhich were partially offset by an increase in accounts receivable and a decrease in deferred revenue. These items were partially offset by cash provided from operating earnings.

During the threesix months ended JulyOctober 31, 2008, net cash of $744,000$607,000 was used by investing activities, primarily for capital expenditures. This compares to the use of $459,000$1,208,000 for investing activities in the samecomparable period of the prior year, primarily for capital expenditures.

The Company’s financing activities providedused cash of $862,000$107,000 during the threesix months ended JulyOctober 31, 2008. Cash providedused included $1,156,000 received from short-term borrowings which was partially offset by cash dividends paid of $205,000 and$408,000, payments on obligations of capital leases of $95,000.$192,000, and purchases of treasury stock of $198,000. Cash was provided during this period by an increase of $415,000 in short-term borrowings and $276,000 in proceeds received from the exercise of stock options. Financing activities providedused cash of $996,000$1,372,000 in the same period offor the prior year, which included $1,067,000 received fromincluding $1,153,000 for reduction in short-term borrowings, partially offset by $175,000$351,000 for cash dividends, and $86,000$175,000 for payments on obligations under capital leases, partially offset by $307,000 received from the exercise of capital leases.stock options.

Outlook for Remainder of Fiscal Year 2009

While the Company’s ability to predict future demand for its products continues to be limited given, among other general economic factors affecting the Company and its markets, the Company’s role as subcontractor or supplier to dealers for subcontractors, the Company expects the remainder of fiscal year 2009 to be profitable. In addition to general economic factors affecting the Company and its markets, demand for its products is also dependent upon the number of laboratory construction projects planned and/or current progress in projects already under construction. The Company’s earnings are also impacted by increased costs of raw materials, including stainless steel, wood, and epoxy resin, and whether the Company is able to increase product prices to customers in amounts that correspond to such increases without materially and adversely affecting sales. Additionally, since prices are normally quoted on a firm basis in the industry, we bear the burden of possible increases in labor and material costs between the quotation of an order and delivery of a product.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain statements in this report constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company’s operations, markets, products, services, and prices, as well as prices for certain raw materials and energy. The cautionary statements made pursuant to the Reform Act herein and elsewhere by the Company should not be construed as exhaustive. The Company cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. In addition, readers are urged to consider statements that include the terms “believes”, “belief”“belief’, “expects”, “plans”, “objectives”, “anticipates”, “intends” or the like to be uncertain and forward-looking. Over time, the Company’s actual results, performance or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by the Company’s forward-looking statements, and such difference might be significant and harmful to stockholders’ interests. Many important factors that could cause such a difference are described under the caption “Risk Factors,” in Item 1A of the Company’s 2008 Annual Report on Form 10-K.

REVIEW BY INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

A review of the interim consolidated financial information included in this Quarterly Report on Form 10-Q for each of the three and six month periods ended JulyOctober 31, 2008 and JulyOctober 31, 2007 has been performed by Cherry, Bekaert & Holland, L.L.P., the Company’s registered public accounting firm. Their report on the interim consolidated financial information follows.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have reviewed the accompanying consolidated balance sheetssheet of Kewaunee Scientific Corporation and its subsidiaries (the “Company”) as of JulyOctober 31, 2008, and the related consolidated statements of operations for the three month and six month periods ended October 31, 2008 and 2007 and the related consolidated statements of cash flows for the three-monthsix-month periods ended JulyOctober 31, 2008 and 2007. These interim consolidated financial statements are the responsibility of the Company’s management.

We conducted our review in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should be made to the interim consolidated financial statements referred to above for them to be in conformity with accounting principles generally accepted in the United States of America.

We previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet as of April 30, 2008, and the related statements of operations, of stockholder’s equity and of cash flows for the year then ended (not presented herein) and in our report dated July 12, 2008, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of April 30, 2008 is fairly stated in all material respects in relation to the consolidated financial statement from which it has been derived.

/s/ Cherry, Bekaert & Holland, L.L.P.

Charlotte, North Carolina

September 9,November 26, 2008

Item 3.Quantitative and Qualitative Disclosures About Market Risk

There are no material changes to the disclosures made on this matter in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2008.

 

Item 4.Controls and Procedures

(a) Evaluation of disclosure controls and procedures

(a)Evaluation of disclosure controls and procedures

An evaluation was performed under the supervision and the participation of the Company’s management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of JulyOctober 31, 2008. Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that, as of JulyOctober 31, 2008, the Company’s disclosure controls and procedures were adequate and effective and designed to ensure that all material information required to be filed in this quarterly report is made known to them by others within the Company and its subsidiaries.

(b) Changes in internal controls

(b)Changes in internal controls

There was no significant change in the Company’s internal control over financial reporting that occurred during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

 

Item 4.Submission of Matters to a Vote of Security Holders

The Company’s Annual Meeting of Stockholders was held on August 27, 2008. EachInformation regarding the results of this meeting are incorporated by reference from Item 4 of Part II of the nomineesCompany’s Report on Form 10-Q for Class I directors was re-elected for a three-year term. The votes cast for and withheld from each such director were as follows:the three months ended July 31, 2008.

 

Director

  For  Withheld

Wiley N. Caldwell

  1,985,744  373,236

Silas Keehn

  1,962,872  396,108

David S. Rhind

  2,046,523  312,457
Item 5.Other Information

The proposalOn October 28, 2008, the Company amended its revolving credit facility with Bank of America, N.A. (the “Bank”) increasing the credit facility to adopt$14,000,000 from $12,000,000 under the 2008 Key Employee Stock Option Plan was also approved. The votes cast forsame terms and conditions as the Plan were as follows:$12,000,000 credit facility.

 

For  Against  Abstain
1,261,344  431,555  2,519

Item 6.Exhibits and Reports on Form 8-K

 

10.50

Loan and Security Agreement dated as of December 10, 2007 between Bank of America N.A. and the Company (incorporated by reference to Exhibit 10.50 to the Company’s Quarterly Report on Form 10-Q for the period ended October 31, 2007).

10.50A

Amendment dated October 28, 2008 to Loan and Security Agreement dated as of December 10, 2007 between Bank of America N.A. and the Company.

31.1

  Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

  Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

  Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

  Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 KEWAUNEE SCIENTIFIC CORPORATION
 

(Registrant)

Date: SeptemberDecember 12, 2008 By 

/s/ D. Michael Parker

  D. Michael Parker
  

(As duly authorized officer and Senior Vice

President, Finance and Chief Financial Officer)

 

1715